2025: Novo Nordisk announced positive Phase 3 ESSENCE trial results for semaglutide in early Alzheimer's disease, reporting statistically significant slowing of cognitive and functional decline a breakthrough data package that could establish GLP-1 therapy as a neuroprotective agent and open an addressable market of 6.5 million Alzheimer's patients in the U.S
In the SURMOUNT-5 phase 3b trial involving adults with obesity without type 2 diabetes, tirzepatide was superior to semaglutide in reducing body weight and waist circumference
Keep reading to learn more, explore the FAQs below and visit the Quarterly Drug Pipeline for deeper insights into these anticipated therapies in development
[4] One study which involved murine models with a gene ablation of GHRH (referred to as GHRHKO), commented that the introduction of CJC-1295 might exhibit tissue-specific action
Acetyl L-carnitine (ALCAR) is a naturally occurring amino acid derivative that plays crucial roles in cellular metabolism, particularly in energy production and fatty acid metabolism
If you'd like to see the all of the APLB dupes that we've found, check out our best APLB dupes guide